Nuclear Power Corporation of India Limited Haematology Reagents Tender Surat Gujarat 2017 MDR Compliance 2026

Tender Overview

Nuclear Power Corporation of India Limited (Department of Atomic Energy) invites bids for Haematology Analyzer Reagents (V2) in Surat, Gujarat. Scope: supply of reagents only, with quantity adjustments allowed up to 25% of bid quantity and extended periods under option clause. Estimated value and EMD are not publicly disclosed. The focus is on compliance with medical device regulations and drug acts, plus valid medical device licenses. This procurement emphasizes reagent reactivity, packaging volume, and regulatory conformity to enable reliable hematology analysis for NPCIL facilities. The tender’s unique aspect is its strict regulatory alignment, including MDR 2017 amendments, and the GST considerations noted in terms.

Technical Specifications & Requirements

• Product information: Reagent type and reactivity; total reagent volume per pack; packaging details.
• Compliance: Must meet Drugs and Cosmetic Act 1940 and Medical Device Rules (MDR) 2017 as amended; valid Medical Device license from competent authority.
• Delivery scope: Only supply of goods; delivery terms subject to option clause adjustments (up to 25% quantity and extension). Specified delivery periods align with purchase orders and extended windows.
• Logistics/verification: Invoices to be raised in consignee name with consignee GSTIN; GST implications as per actuals or lower applicable rate; GST portal proof required.
• Quality controls: Reagents must be compatible with haematology analyzers; documentation to prove regulatory compliance; no BOQ items listed.

Terms, Conditions & Eligibility

• Option clause: Quantity may be increased/decreased by up to 25%, with extension rules as described.
• GST & invoicing: GST to be determined by bidder; invoice must reflect consignee GSTIN; GST payment proof required.
• Contract risk: Supplier cannot assign or subcontract without prior written consent; joint liability maintained.
• Payment terms: Not explicitly defined; GST compliance emphasized; invoice generation via GeM with GST portal screenshot.
• Delivery risk: Contract termination rights for non-delivery or material breach; timely replacement of defective materials may be mandated.
• Important documents: GSTIN, PAN, experience certificates, medical device licenses, technical compliance, and OEM authorizations as applicable.